Adage Capital Partners’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-9,085
Closed -$1.91M – 952
2025
Q3
$1.91M Buy
+9,085
New +$1.6M ﹤0.01% 810
2022
Q4
– Sell
-688
Closed -$659K – 1004
2022
Q3
$659K Buy
+688
New +$683K ﹤0.01% 906

Other funds holding GOSS

Adage Capital Partners's GOSS Position: Q4 2025 in Review

Adage Capital Partners sold out of Gossamer Bio (GOSS) in Q4 2025, closing a stake of 9,085 shares — an estimated $1.91M sold.

Adage Capital Partners first reported a position in GOSS in Q3 2022 and held it in 2 quarters. The position peaked at $1.91M in Q3 2025. 192 funds tracked by Wall St. Rank hold GOSS as of Q4 2025.

  • Adage Capital Partners reported no remaining Gossamer Bio position as of Q4 2025 after selling out during the quarter.
  • Adage Capital Partners sold 9,085 Gossamer Bio shares in Q4 2025, an estimated $1.91M.
  • Adage Capital Partners first reported a position in Gossamer Bio in Q3 2022 and held it in 2 quarters.
  • Adage Capital Partners's Gossamer Bio position peaked at $1.91M in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2025.

Based on Adage Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.